Source: http://slideplayer.com/slide/751476/
Timestamp: 2018-08-14 06:56:42
Document Index: 484224376

Matched Legal Cases: ['art 1', 'art 2', 'art 3', 'art 4', 'ART 1', 'ART 2', 'ART 3', 'ART 4']

Cartagena Protocol on Biosafety -Reducing the Environmental Risks of Modern Biotechnology Secretariat of the Convention on Biological Diversity https://bch.cbd.int/protocol/ - ppt download
Presentation on theme: "Cartagena Protocol on Biosafety -Reducing the Environmental Risks of Modern Biotechnology Secretariat of the Convention on Biological Diversity https://bch.cbd.int/protocol/"— Presentation transcript:
1 Cartagena Protocol on Biosafety -Reducing the Environmental Risks of Modern Biotechnology Secretariat of the Convention on Biological Diversity https://bch.cbd.int/protocol/ https://bch.cbd.int/protocol/
2 Presentation Outline Part 1: What is the Protocol on Biosafety? Part 2: How does the Protocol work? Part 3: Why is it important? Part 4: Concluding Remarks
3 II PART 1: What is the Protocol on Biosafety? An agreement between different countries An agreement between different countries Negotiated under the Convention on Biological Diversity (CBD) Negotiated under the Convention on Biological Diversity (CBD) Adopted 29 January 2000 after 4 years of intense negotiations Adopted 29 January 2000 after 4 years of intense negotiations Entry into force: 9 September 2003 Entry into force: 9 September 2003 166 ratifications/ accessions 166 ratifications/ accessions 6 meeting of the governing body (COP- MOP) 6 meeting of the governing body (COP- MOP) Next COP-MOP: 6 - 10 October 2014; Republic of Korea Next COP-MOP: 6 - 10 October 2014; Republic of Korea
4 Objective To contribute to ensuring the safe transfer, handling and use of LMOs resulting from modern biotechnology that may have adverse effects on the biological diversity, taking also into account risks to human health
5 Scope Applies to: Transboundary movement, transit, handling and use of all LMOs that may have adverse effects on biodiversity, taking also into account risks to human health Transboundary movement, transit, handling and use of all LMOs that may have adverse effects on biodiversity, taking also into account risks to human healthExclusion: Pharmaceuticals for humans that are addressed by other international agreements or organisations Pharmaceuticals for humans that are addressed by other international agreements or organisations
6 For millennia, farmers have selected and saved their best seeds and animals for breeding so that future varieties and breeds would have better qualities in terms of size, taste, growth rate or yield. In recent years, new techniques, referred to as modern biotechnology, have allowed scientists to modify plants, animals and microorganisms at rates faster than those of conventional methods They can extract genes from one organism and inserting them into another, resulting in living modified organisms (LMOs)
7 Modern biotechnology promises to improve human wellbeing, for example, by enhancing agricultural productivity However, there are concerns about the potential risks that LMOs may pose to biological diversity and to human health Environmental concerns (examples) Impacts on non-target organisms Impacts on non-target organisms Transfer of genes from cultivated species to wild relatives Transfer of genes from cultivated species to wild relatives Potential to become super weeds Potential to become super weeds Ripple effects within ecosystems – difficult to predict Ripple effects within ecosystems – difficult to predict Health concerns (examples) Potential allergenicity Potential allergenicity Antibiotic-resitance Antibiotic-resitance
8 Categories of LMOs LMOs for intentional introduction into the environment (such as seeds and live fish) LMOs for intentional introduction into the environment (such as seeds and live fish) LMOs intended for direct use as food, feed or processing, LMOs-FFP (such as agricultural commodities – corn, canola and cotton) LMOs intended for direct use as food, feed or processing, LMOs-FFP (such as agricultural commodities – corn, canola and cotton) LMOs for contained use (such as bacteria for laboratory scientific experiment) LMOs for contained use (such as bacteria for laboratory scientific experiment)
9 PART 2: How does the Protocol work? The Protocol establishes rules and procedures to regulate the movements of LMOs from one country to another Some of the measures include: Risk Assessment –scientific, case by case Risk Assessment –scientific, case by case Safe handling, transport, packaging and proper identification of LMO shipments Safe handling, transport, packaging and proper identification of LMO shipments Information sharing through Biosafety Clearing-House (BCH) Information sharing through Biosafety Clearing-House (BCH) Capacity-Building Capacity-Building Public Awareness and participation Public Awareness and participation Compliance procedures and mechanisms Compliance procedures and mechanisms Liability and redress Liability and redress
10 Precautionary Approach Objective: Safe Transfer, Handling and Use of LMOs Biosafety Clearing-House (BCH), Capacity-Building, Compliance and COP-MOP Supporting Mechanisms: Risk Assessment Risk Assessment Risk Management Risk Management Information Sharing Information Sharing Public Awareness & Public Participation Public Awareness & Public Participation Rules/ Procedures: Rules/ Procedures: - AIA Procedure - AIA Procedure - Procedure for FFP - Procedure for FFP Decision - making Decision - making Handling, Transport, Packaging and Identification: Handling, Transport, Packaging and Identification: - Documentation for Shipment - Documentation for Shipment - Standards Key Provisions of the Protocol
11 Procedures for Transboundary Movements of LMOs There are two key procedures: There are two key procedures: – The Advance Informed Agreement (AIA) procedure – Procedures for LMOs intended for direct use as food, feed or for processing (LMOs- FFP)
12 AIA Procedure: -Notification -Acknowledgement -Decision based on -Risk Assessment Possible Transboundary Movement of LMOs FFP Procedure: -Approval for domestic use -Import decision under domestic framework or Risk assessment/ Annex III For intentional release into environment For food, feed or processing (FFP) Final Decision - Public Participation - Socio-Economic Considerations Transboundary Movement if approved Requirements for safe handling, transport, packaging and documentation Monitoring Review of Decision Risk Management New information Key procedures BCH BCH
13 PART 3: Why is it important? The Protocol is a key agreement contributing to biodiversity conservation and sustainable development Biodiversity is the basis of human wellbeing As biodiversity declines, so too does the Earths capacity to support human life All humanity must safeguard biodiversity from all threats and to stop or reduce its loss
14 PART 4: Concluding remarks Several LMOs have been placed on the market Several LMOs have been placed on the market It is important to ensure LMOs have no negative effects on biological diversity and human health It is important to ensure LMOs have no negative effects on biological diversity and human health The Protocol establishes procedures and mechanisms for doing so The Protocol establishes procedures and mechanisms for doing so The CPB recognises the potential of biotechnology if developed and used with adequate safety measures The CPB recognises the potential of biotechnology if developed and used with adequate safety measures Biosafety is concern for all humanity. Every individual has a responsibility and a role to play in ensuring that LMOs do not adversely affect biodiversity and human health. Biosafety is concern for all humanity. Every individual has a responsibility and a role to play in ensuring that LMOs do not adversely affect biodiversity and human health.
15 Biosafety is concern for all humanity Every individual has a responsibility and a role to play in making sure that living modified organisms do not negatively impact biodiversity and human health
16 Contacts for Further Information Secretariat of the Convention on Biological Diversity 413 Saint-Jacques Street, suite 800 Montreal, Quebec Canada H2Y 1N9 Tel.: +1 (514) 288-2220 Fax: +1 (514) 288-6588 E-mail: secretariat@cbd.int Protocol website: https://bch.cbd.int/protocol/ Biosafety Clearing-House: http://bch.cbd.int/
Download ppt "Cartagena Protocol on Biosafety -Reducing the Environmental Risks of Modern Biotechnology Secretariat of the Convention on Biological Diversity https://bch.cbd.int/protocol/"
Ppt on sports day outfits Ppt on google glasses technology Ppt on network theory business Adrenal gland anatomy and physiology ppt on cells Ppt on product advertising letter Ppt on gujarat election 2012 Disaster management ppt on uttarakhand Ppt on rbi reforms define Ppt on peak load pricing of electricity Convert pdf to ppt online nitro
Biosafety Capacity Building Initiatives in India
Areas to discuss The Convention Text + Articles and definitions
Overview of the Cartagena Protocol on Biosafety and it's Proposed Programme of Work on Public Awareness, Education and Participation Erie Tamale Secretariat.
INCEPTION WORKSHOP BACKGROUND PAPER BIOSAFETY IMPLEMENTATION PROJECT FOR ARAB REPUBLIC OF EGYPT GEF/UNEP DR. NERMEEN EL-TAYEB ASSISTANT TO THE INTERIM.
PROJECT INCEPTION WORKSHOP on BIOSAFETY IMPLEMENTATION PROJECT OF EGYPT 9 – 10 July 2007.